FNA - Paragon 28, Inc. Stock Price, Fair Value and News

$13.60-0.10 (-0.73%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

FNA Price Action

Last 30 days

3.8%

Last 90 days

0.7%

Trailing 12 Months

32.9%

FNA RSI Chart

FNA Valuation

Market Cap

1.1B

Price/Earnings (Trailing)

-20.48

Price/Sales (Trailing)

4.37

EV/EBITDA

-52.03

Price/Free Cashflow

-41.23

FNA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

FNA Fundamentals

FNA Revenue

Revenue (TTM)

256.2M

FNA Earnings

Earnings (TTM)

-54.6M

FNA Profitability

Operating Margin

74.75%

EBT Margin

-20.88%

Return on Equity

-41.84%

Return on Assets

-18.79%

Free Cashflow Yield

-2.43%

FNA Investor Care

Shares Dilution (1Y)

1.46%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	225.4M	235.4M	245.0M	256.2M
2023	192.0M	200.6M	207.3M	216.4M
2022	155.7M	162.5M	172.7M	181.4M
2021	120.1M	129.2M	138.3M	147.5M
2020	0	0	108.6M	111.0M
2019	0	0	0	106.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About Paragon 28, Inc.

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

CEO	Mr. Albert DaCosta
WEBSITE	paragon28.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	463

Paragon 28, Inc. Frequently Asked Questions

What is the ticker symbol for Paragon 28, Inc.? What does FNA stand for in stocks?

FNA is the stock ticker symbol of Paragon 28, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Paragon 28, Inc. (FNA)?

As of Wed Dec 03 2025, market cap of Paragon 28, Inc. is 1.09 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of FNA stock?

You can check FNA's fair value in chart for subscribers.

Is Paragon 28, Inc. a good stock to buy?

The fair value guage provides a quick view whether FNA is over valued or under valued. Whether Paragon 28, Inc. is cheap or expensive depends on the assumptions which impact Paragon 28, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FNA.

What is Paragon 28, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, FNA's PE ratio (Price to Earnings) is -20.48 and Price to Sales (PS) ratio is 4.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FNA PE ratio will change depending on the future growth rate expectations of investors.